07 Dec 2007 Intercell Submits Marketing Authorization Application (MAA) to EMEA for Licensure of Japanese Enceph
06 Dec 2007 AVANT Immunotherapeutics Achieves Immune Responses Against Cholera, Typhoid and Enterotoxigenic E. coli with a Single-Dose, Oral Combination Vaccine
06 Dec 2007 Nventa completes enrollment and initial dosing of second cohort in phase 1 hspE7 safety trial
04 Dec 2007 SSI, Intercell and Aeras announce start of clinical trial for novel vaccine candidate against TB
29 Nov 2007 Bavarian Nordic A/S reports positive data from first EUA enabling study with IMVAMUNE(R) smallpox vaccine
29 Nov 2007 Cytos Biotechnology announces start of two phase II studies
28 Nov 2007 Oralair(R) Grasses: Positive results of VO52.06 paediatric study
27 Nov 2007 Nventa updates progress with new HspE7 in Phase 1 trial in cervical dysplasia
27 Nov 2007 Inovio Biomedical Partner Tripep Treats First Subject in Phase I/II Study of Novel Hepatitis C DNA Vaccine
23 Nov 2007 New data published in The Lancet show GSK's rotavirus vaccine Rotarix(R) offers sustained and broad protection against all common circulating rotavirus types
22 Nov 2007 Diamyd Executes Agreement With US National Institutes of Health For a Type 1 Diabetes Trial With The Experimental Diamyd(R) Diabetes Vaccine
22 Nov 2007 New promising results published on Pharmexa's PADRE(R) epitope in Alzheimer's vaccine
20 Nov 2007 Cytos Biotechnology presents encouraging phase IIa study results for its melanoma vaccine CYT004-MelQbG10
19 Nov 2007 Curalogic has commenced a Phase III clinical study with the grass product
19 Nov 2007 AVANT's Oral Combined Enterotoxigenic E. coli-Cholera Vaccine to Enter Phase 1 Safety Study Funded by the NIH
19 Nov 2007 Pharmexa provides update on the HeptoVax trial of GV1001 in liver cancer
15 Nov 2007 Sanofi Pasteur and Acambis join forces to bring West Nile vaccine to market
15 Nov 2007 New data for Menveo(TM) vaccine show excellent immune response and broad protection for infants against meningococcal meningitis
13 Nov 2007 AVAX Technologies announces the initiation of its Phase III Registration trial of M-Vax(R) in Metastatic Melanoma
12 Nov 2007 Dynavax Presents New Analysis of TOLAMBA(TM) Data at ACAAI Meeting
09 Nov 2007 Promising clinical results from new HIV vaccine
07 Nov 2007 Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months
07 Nov 2007 Sanofi Pasteur initiates phase II trial of cell
06 Nov 2007 Presentation of phase IIa results for Cytos Biotechnology’s hypertension vaccine at the American Heart Association Scientific Sessions 2007
06 Nov 2007 GlobeImmune Announces Presentation of Results from a Randomized Phase 1b Study of the GI-5005 Tarmogen in Patients with Chronic Hepatitis C Infection

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up